Navigation Links
Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies
Date:5/31/2008

can Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network recommend the use of Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive. For more information about Oncotype DX, please visit http://www.oncotypedx.com.

About Genomic Health

Genomic Health, Inc. (Nasdaq: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(R), which has been shown to predict the likelihood chemotherapy benefit as well as recurrence in early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's belief that the results of these studies could lead to the development of new tests for predicting the benefit of certain targeted therapies used in the treatment of cancer. These risks and uncertainties include, but are not limited to: the results of additional clinical studies; the risk that we may not obtain sufficient levels of reimbursement for any future tests we may develop; our ability to develop and commercialize new products; the risks and uncertainties associated with the regulation of our tests by FDA; our ability to obtain c
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
2. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
5. Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Companys MicroRNA Technology
6. Columbia University Medical Center and Rosetta Genomics Announce Columbia Universitys Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica
7. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
8. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
10. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
11. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... De Pfizer Clinical Research Unit (PCRU) heeft ... van Japanse komaf voor medewerking aan klinisch onderzoek. De ... één van twee onderzoekseenheden van Pfizer , een ... door de ontdekking en ontwikkeling van nieuwe medicijnen. Om ... mannen en vrouwen van Japanse komaf – leeftijd 18 ...
(Date:7/30/2014)... 2014  Cepheid (Nasdaq: CPHD ) ... Premier will end on September 30, 2014.  Customers ... able to continue their relationship with Cepheid through ... and ROi, in addition to the recently announced ... "Cepheid has always recognized and supported the ...
(Date:7/30/2014)... 30, 2014 The Board of Directors ... last evening expressed support for the "Pharmacists, Patient ... of Pharmacy Practitioners (JCPP).  As a JCPP member, ... two-year period to develop a scalable, viable and ... "Pharmacists are fast becoming one of the ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2
... April 5, 2011 Danaher Corporation (NYSE: ... been promoted to Senior Vice President and Amir Aghdaei ... and Group Executive of Danaher. In his ... Danaher,s Dental segment, which includes KaVo Group and Sybron ...
... 5, 2011 Practice Fusion, the fastest growing ... $23 million Series B round of financing led ... Management and Glynn Capital Management, as well as ... round brings the company,s total funding to $30 ...
Cached Medicine Technology:Danaher Announces Executive Appointments 2Founders Fund Leads $23 Million Practice Fusion Financing Round 2Founders Fund Leads $23 Million Practice Fusion Financing Round 3Founders Fund Leads $23 Million Practice Fusion Financing Round 4Founders Fund Leads $23 Million Practice Fusion Financing Round 5
(Date:7/31/2014)... NJ (PRWEB) July 31, 2014 A cancer ... of people survive cancer and resume normal lives. This is ... Cancer Society, will affect one in seven American men but ... has a five-year survival rate of nearly 100% and a ... illness but most men diagnosed with the disease do not ...
(Date:7/31/2014)... its latest blog post, Best Drug Rehabilitation , which ... during a stay in rehab can make a big difference ... on nine secrets that addicts don’t want others to know. ... an addict from a mile away, and totally understand what’s ... Per Wickstrom . “However, take it from me: spotting ...
(Date:7/31/2014)... In its latest blog post, Best Drug ... family close by during a stay in rehab can make ... successful, is looking at 10 tips to help drug or ... is a lifelong process, and one that former addicts and ... compromise,” commented Best Drug Rehabilitation’s CEO Per Wickstrom . ...
(Date:7/31/2014)... 31, 2014 Thanks to its ... erythritol has long been used as a medium ... and monk fruit. However consistent, dependable sourcing of ... to meet food and beverage manufacturers’ increasing needs ... has launched GMO-free ErysweetTM Erythritol. , “Erysweet ...
(Date:7/31/2014)... Arizona (PRWEB) July 31, 2014 Nuanced ... announce the launch of the Nuanced Medical website ... created for the needs of the Medical Industry. , ... products and services for medical practices to meet continuously ... regulations being the HIPAA Act (Health Insurance Portability and ...
Breaking Medicine News(10 mins):Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 2Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 3Health News:Restoring Intimacy after Prostate Cancer; Dr. Daniel Watter with Morris Psychological Group Offers Tips for Patients and their Partners 4Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 2Health News:Latest Best Drug Rehabilitation Blog Posts Focuses on Nine Secrets Addicts Don’t Want Others to Know 3Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Nuanced Media, HIPAA Certified Agency, Launches Medical Web Design Service Website 2
... drugs , , WEDNESDAY, June 17 (HealthDay News) -- ... invade the nervous system of patients with a blood-borne ... the development of drugs that block these molecules and ... which primarily strikes children and adolescents, the bone marrow ...
... ... has been regularly engaging its healthcare provider customers in discussions about healthcare reform, the ... technology to address short and long-term healthcare objectives. , ... Stamford, CT (Vocus) June 18, 2009 -- ...
... Today the National Multiple Sclerosis Society - Wisconsin ... 2009 Physician Appreciation Award. The recognition commends Dr. Khatri ... and his research to treat it. , , ... honored to receive this recognition," says Dr. Khatri, medical ...
... 17 PRA International, a leading Clinical Research Organization, announces ... Information Association (DIA) meeting June 21 - 25 in San ... Executive Director of Medical Affairs will make a presentation entitled ... , In addition, Dr. Starkey and other PRA medical, ...
... , Redskins Kicker Shaun Suisham,s Foursome Takes First Place , ... 23rd Annual Maryland Golf Classic presented by Capital Carpets & ... kidney disease in the Washington DC area, a region that ... The tournament took place on June 15 at the picturesque ...
... quality improvement and affordable coverage for all Americans , ... Majority Leaders Howard Baker, Tom Daschle and Bob Dole, ... today released a bipartisan, budget-neutral framework for comprehensive health ... health coverage. The Leaders, Project on the State of ...
Cached Medicine News:Health News:Taking Aim at Relapse of Leukemia in Kids 2Health News:IVANS Hit Experts Available To Discuss the Dept. of HHS Recommendation Of “Meaningful Use” and How Potential Tighter Standards Will Impact the Provider Community 2Health News:IVANS Hit Experts Available To Discuss the Dept. of HHS Recommendation Of “Meaningful Use” and How Potential Tighter Standards Will Impact the Provider Community 3Health News:Aurora Physician Recognized for Multiple Sclerosis Care 2Health News:PRA International Experts Present at the 45th Annual DIA Meeting 2Health News:National Kidney Foundation's 23rd Annual Maryland Golf Classic Raises Funds to Fight Kidney Disease 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 2Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 3Health News:Former Senate Majority Leaders Baker, Daschle and Dole Release Bipartisan Framework for Comprehensive Health Reform 4
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: